This index integrates serum levels of cytokeratin-1 (CK-1), epithelial membrane antigen (EMA), albumin, and alpha-fetoprotein (AFP) into a formula designed to maximize discrimination between HCC and non-malignant liver disease. This evidence concerns the gene AFP and hepatocellular carcinoma.